BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24875537)

  • 21. A sphingosine kinase-1 inhibitor, SKI-II, induces growth inhibition and apoptosis in human gastric cancer cells.
    Li PH; Wu JX; Zheng JN; Pei DS
    Asian Pac J Cancer Prev; 2014; 15(23):10381-5. PubMed ID: 25556479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.
    Schnute ME; McReynolds MD; Kasten T; Yates M; Jerome G; Rains JW; Hall T; Chrencik J; Kraus M; Cronin CN; Saabye M; Highkin MK; Broadus R; Ogawa S; Cukyne K; Zawadzke LE; Peterkin V; Iyanar K; Scholten JA; Wendling J; Fujiwara H; Nemirovskiy O; Wittwer AJ; Nagiec MM
    Biochem J; 2012 May; 444(1):79-88. PubMed ID: 22397330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sphingosine kinase 1 protects renal tubular epithelial cells from renal fibrosis via induction of autophagy.
    Du C; Ren Y; Yao F; Duan J; Zhao H; Du Y; Xiao X; Duan H; Shi Y
    Int J Biochem Cell Biol; 2017 Sep; 90():17-28. PubMed ID: 28733250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects on cell death, self-renewal, and invasion.
    Sousa N; Geiß C; Bindila L; Lieberwirth I; Kim E; Régnier-Vigouroux A
    BMC Cancer; 2023 Aug; 23(1):762. PubMed ID: 37587449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth.
    Xue Y; Jiang K; Ou L; Shen M; Yang Y; Lu J; Xu W
    Cell Death Dis; 2022 Jul; 13(7):602. PubMed ID: 35831279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition kinetics and regulation of sphingosine kinase 1 expression in prostate cancer cells: functional differences between sphingosine kinase 1a and 1b.
    Lim KG; Tonelli F; Berdyshev E; Gorshkova I; Leclercq T; Pitson SM; Bittman R; Pyne S; Pyne NJ
    Int J Biochem Cell Biol; 2012 Sep; 44(9):1457-64. PubMed ID: 22634604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blocking SphK1/S1P/S1PR1 Signaling Pathway Alleviates Lung Injury Caused by Sepsis in Acute Ethanol Intoxication Mice.
    Chen L; Li L; Song Y; Lv T
    Inflammation; 2021 Dec; 44(6):2170-2179. PubMed ID: 34109517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells.
    Leroux ME; Auzenne E; Evans R; Hail N; Spohn W; Ghosh SC; Farquhar D; McDonnell T; Klostergaard J
    Prostate; 2007 Nov; 67(15):1699-717. PubMed ID: 17879964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cells.
    Watson DG; Tonelli F; Alossaimi M; Williamson L; Chan E; Gorshkova I; Berdyshev E; Bittman R; Pyne NJ; Pyne S
    Cell Signal; 2013 Apr; 25(4):1011-7. PubMed ID: 23314175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In Vivo.
    Venant H; Rahmaniyan M; Jones EE; Lu P; Lilly MB; Garrett-Mayer E; Drake RR; Kraveka JM; Smith CD; Voelkel-Johnson C
    Mol Cancer Ther; 2015 Dec; 14(12):2744-52. PubMed ID: 26494858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Building a better sphingosine kinase-1 inhibitor.
    Lynch KR
    Biochem J; 2012 May; 444(1):e1-2. PubMed ID: 22533672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation.
    Lavieu G; Scarlatti F; Sala G; Carpentier S; Levade T; Ghidoni R; Botti J; Codogno P
    J Biol Chem; 2006 Mar; 281(13):8518-27. PubMed ID: 16415355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes.
    Shin SH; Kim HY; Yoon HS; Park WJ; Adams DR; Pyne NJ; Pyne S; Park JW
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short Periods of Hypoxia Upregulate Sphingosine Kinase 1 and Increase Vasodilation of Arteries to Sphingosine 1-Phosphate (S1P) via S1P
    Alganga H; Almabrouk TAM; Katwan OJ; Daly CJ; Pyne S; Pyne NJ; Kennedy S
    J Pharmacol Exp Ther; 2019 Oct; 371(1):63-74. PubMed ID: 31371480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The regulation of p53, p38 MAPK, JNK and XBP-1s by sphingosine kinases in human embryonic kidney cells.
    Alsanafi M; Kelly SL; McNaughton M; Merrill AH; Pyne NJ; Pyne S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Apr; 1865(4):158631. PubMed ID: 31954175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Native and Polyubiquitinated Forms of Dihydroceramide Desaturase Are Differentially Linked to Human Embryonic Kidney Cell Survival.
    Alsanafi M; Kelly SL; Jubair K; McNaughton M; Tate RJ; Merrill AH; Pyne S; Pyne NJ
    Mol Cell Biol; 2018 Dec; 38(23):. PubMed ID: 30224516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular Effects of Pharmacological Targeting of Sphingosine Kinase 1.
    Józefczuk E; Nosalski R; Saju B; Crespo E; Szczepaniak P; Guzik TJ; Siedlinski M
    Hypertension; 2020 Feb; 75(2):383-392. PubMed ID: 31838904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of sphingosine kinase/sphingosine 1-phosphate metabolic pathway in spondyloarthritis.
    Bougault C; El Jamal A; Briolay A; Mebarek S; Boutet MA; Garraud T; Le Goff B; Blanchard F; Magne D; Brizuela L
    Bone; 2017 Oct; 103():150-158. PubMed ID: 28684192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel sphingosine kinase inhibitor induces autophagy in tumor cells.
    Beljanski V; Knaak C; Smith CD
    J Pharmacol Exp Ther; 2010 May; 333(2):454-64. PubMed ID: 20179157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy.
    Yaghobian D; Don AS; Yaghobian S; Chen X; Pollock CA; Saad S
    Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):56-66. PubMed ID: 26414003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.